{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:25:35Z","timestamp":1788337535064,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"USTC Research Funds of the Double First-Class Initiative","award":["YD9115202649"],"award-info":[{"award-number":["YD9115202649"]}]},{"name":"Anhui Province\u2019s Health and Wellness Research Program","award":["AHWJ2023A30186"],"award-info":[{"award-number":["AHWJ2023A30186"]}]},{"name":"Joint Fund for Medical Artificial Intelligence of USTC","award":["MAI2023C006"],"award-info":[{"award-number":["MAI2023C006"]}]},{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82271991"],"award-info":[{"award-number":["82271991"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hefei National Comprehensive Science Center - Institute of Pioneering Medicine and Cutting","award":["2025IHM01140"],"award-info":[{"award-number":["2025IHM01140"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"DOI":"10.1186\/s40644-026-01110-z","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T16:33:58Z","timestamp":1787157238000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dual-energy CT extracellular volume fraction for predicting the chemotherapeutic response in pancreatic ductal adenocarcinoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Shuai","family":"Ming","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongji","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiyun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"1110_CR1","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","volume":"405","author":"TF Stoop","year":"2025","unstructured":"Stoop TF, Javed AA, Oba A, Koerkamp BG, Seufferlein T, Wilmink JW, et al. Pancreatic cancer. Lancet. 2025;405:1182\u2013202.","journal-title":"Lancet"},{"key":"1110_CR2","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1110_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S2468-1253(23)00405-3","volume":"9","author":"KJ Labori","year":"2024","unstructured":"Labori KJ, Bratlie SO, Andersson B, Angelsen JH, Bi\u00f6rserud C, Bj\u00f6rnsson B, et al. Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial. Lancet Gastroenterol Hepatol. 2024;9:205\u201317.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1110_CR4","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41571-023-00746-1","volume":"20","author":"C Springfeld","year":"2023","unstructured":"Springfeld C, Ferrone CR, Katz MHG, Philip PA, Hong TS, Hackert T, et al. Neoadjuvant therapy for pancreatic cancer. Nat Reviews Clin Oncol. 2023;20:318\u201337.","journal-title":"Nat Reviews Clin Oncol"},{"key":"1110_CR5","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/S1470-2045(25)00363-8","volume":"26","author":"QP Janssen","year":"2025","unstructured":"Janssen QP, van Dam JL, van Bekkum ML, Bonsing BA, Bos H, Bosscha KP, et al. Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy in resectable and borderline resectable pancreatic cancer (PREOPANC-2): a multicentre, open-label, phase 3 randomised trial. Lancet Oncol. 2025;26:1346\u201356.","journal-title":"Lancet Oncol"},{"key":"1110_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41392-024-02097-4","volume":"10","author":"T Zhan","year":"2025","unstructured":"Zhan T, Betge J, Schulte N, Dreikhausen L, Hirth M, Li M, et al. Digestive cancers: mechanisms, therapeutics and management. Signal Transduct Target Ther. 2025;10:24.","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"1110_CR7","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/S1470-2045(24)00511-4","volume":"25","author":"L Mastrantoni","year":"2024","unstructured":"Mastrantoni L, Chiaravalli M, Spring A, Beccia V, Di Bello A, Bagal\u00e0 C, et al. Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: a systematic review and Bayesian network meta-analysis. Lancet Oncol. 2024;25(12):1655\u201365.","journal-title":"Lancet Oncol"},{"key":"1110_CR8","doi-asserted-by":"publisher","first-page":"115647","DOI":"10.1016\/j.addr.2025.115647","volume":"224","author":"T du Toit-Thompson","year":"2025","unstructured":"du Toit-Thompson T, Leck L, Gillson J, Pavlakis N, Gill AJ, Samra JS, et al. Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies. Adv Drug Deliv Rev. 2025;224:115647.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"1110_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41572-026-00699-6","volume":"12","author":"S Roth","year":"2026","unstructured":"Roth S, Apte M, Balachandran VP, Biffi G, Conroy T, Cukierman E, et al. Pancreatic cancer. Nat Rev Dis Primers. 2026;12(1):23.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"1110_CR10","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jcmg.2023.11.011","volume":"17","author":"BL Gerber","year":"2024","unstructured":"Gerber BL. Assessment of the extracellular matrix by CT extracellular volume fraction. JACC Cardiovasc imaging. 2024;17(5):529\u201332.","journal-title":"JACC Cardiovasc imaging"},{"key":"1110_CR11","first-page":"0937","volume":"8","author":"Q Yang","year":"2025","unstructured":"Yang Q, Mao Y, Han Y, Li K, Hu W, Zhou J, et al. Noninvasive computed tomography-based quantification of tumor fibrosis predicts pancreatic cancer response to Gemcitabine\/Nab-Paclitaxel. Res (Wash DC). 2025;8:0937.","journal-title":"Res (Wash DC)"},{"key":"1110_CR12","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1097\/JS9.0000000000002059","volume":"111","author":"S Shi","year":"2025","unstructured":"Shi S, Liu R, Zhou J, Liu J, Lin H, Mo J, et al. Development and validation of a CT-based radiomics model to predict survival-graded fibrosis in pancreatic ductal adenocarcinoma. Int J Surg. 2025;111:950\u201361.","journal-title":"Int J Surg"},{"key":"1110_CR13","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s00330-019-06517-w","volume":"30","author":"Y Fukukura","year":"2020","unstructured":"Fukukura Y, Kumagae Y, Higashi R, Hakamada H, Nakajo M, Maemura K, et al. Extracellular volume fraction determined by equilibrium contrast-enhanced dual-energy CT as a prognostic factor in patients with stage IV pancreatic ductal adenocarcinoma. Eur Radiol. 2020;30:1679\u201389.","journal-title":"Eur Radiol"},{"key":"1110_CR14","doi-asserted-by":"publisher","first-page":"6957","DOI":"10.1007\/s00330-024-10750-3","volume":"34","author":"XH Bai","year":"2024","unstructured":"Bai XH, Yin J, Yu SY, Shu YP, Lu ZP, Jiang KR, et al. Extracellular volume fraction derived from dual-energy CT: a potential predictor for acute pancreatitis after pancreatoduodenectomy. Eur Radiol. 2024;34:6957\u201366.","journal-title":"Eur Radiol"},{"key":"1110_CR15","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.ijrobp.2022.09.084","volume":"115","author":"G Noid","year":"2023","unstructured":"Noid G, Godfrey G, Hall W, Shah J, Paulson E, Knechtges P, et al. Predicting Treatment Response From Extracellular Volume Fraction for Chemoradiation Therapy of Pancreatic Cancer. Int J Radiat Oncol Biol Phys. 2023;115:803\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1110_CR16","doi-asserted-by":"publisher","first-page":"11922","DOI":"10.21037\/qims-2025-905","volume":"15","author":"S Zhong","year":"2025","unstructured":"Zhong S, Yang A, Pan C, Huo Y, Song Q, Li C, et al. Evaluation of histological tumor necrosis in pancreatic ductal adenocarcinoma via the quantitative parameters from enhanced computed tomography and its relationship with tumor prognosis. Quant Imaging Med Surg. 2025;15:11922\u201337.","journal-title":"Quant Imaging Med Surg"},{"issue":"3","key":"1110_CR17","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s00330-024-11330-1","volume":"35","author":"W Liu","year":"2025","unstructured":"Liu W, Chen Y, Xie T, Zhang Z, Wang Y, Xie X, et al. Dual-energy CT extracellular volume fraction predicts tumor collagen ratio and possibly survival for inoperable pancreatic cancer patients. Eur Radiol. 2025;35(3):1451\u201363.","journal-title":"Eur Radiol"},{"key":"1110_CR18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","volume":"62","author":"LH Schwartz","year":"2016","unstructured":"Schwartz LH, Liti\u00e8re S, de Vries E, Ford R, Gwyther S, Mandrekar S, et al. RECIST 1.1-Update and clarification: From the RECIST committee. Eur J Cancer. 2016;62:132\u20137.","journal-title":"Eur J Cancer"},{"key":"1110_CR19","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.2214\/AJR.18.19791","volume":"211","author":"Y Noda","year":"2018","unstructured":"Noda Y, Goshima S, Miyoshi T, Kawada H, Kawai N, Tanahashi Y, et al. Assessing Chemotherapeutic Response in Pancreatic Ductal Adenocarcinoma: Histogram Analysis of Iodine Concentration and CT Number in Single-Source Dual-Energy CT. AJR Am J Roentgenol. 2018;211:1221\u20136.","journal-title":"AJR Am J Roentgenol"},{"key":"1110_CR20","doi-asserted-by":"publisher","first-page":"216782","DOI":"10.1016\/j.canlet.2024.216782","volume":"588","author":"PK Chintamaneni","year":"2024","unstructured":"Chintamaneni PK, Pindiprolu SKSS, Swain SS, Karri VVSR, Nesamony J, Chelliah S, et al. Conquering chemoresistance in pancreatic cancer: Exploring novel drug therapies and delivery approaches amidst desmoplasia and hypoxia. Cancer Lett. 2024;588:216782.","journal-title":"Cancer Lett"},{"key":"1110_CR21","doi-asserted-by":"publisher","first-page":"101064","DOI":"10.1016\/j.drup.2024.101064","volume":"73","author":"Q Lin","year":"2024","unstructured":"Lin Q, Serratore A, Niu J, Shen S, Roy Chaudhuri T, Ma WW, et al. Fibroblast growth factor receptor 1 inhibition suppresses pancreatic cancer chemoresistance and chemotherapy-driven aggressiveness. Drug Resist Updat. 2024;73:101064.","journal-title":"Drug Resist Updat"},{"key":"1110_CR22","doi-asserted-by":"publisher","first-page":"110756","DOI":"10.1016\/j.ejrad.2023.110756","volume":"162","author":"N Fujita","year":"2023","unstructured":"Fujita N, Ushijima Y, Itoyama M, Okamoto D, Ishimatsu K, Wada N, et al. Extracellular volume fraction determined by dual-layer spectral detector CT: Possible role in predicting the efficacy of preoperative neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma. Eur J Radiol. 2023;162:110756.","journal-title":"Eur J Radiol"},{"key":"1110_CR23","doi-asserted-by":"publisher","first-page":"217350","DOI":"10.1016\/j.canlet.2024.217350","volume":"610","author":"B Yu","year":"2025","unstructured":"Yu B, Shao S, Ma W. Frontiers in pancreatic cancer on biomarkers, microenvironment, and immunotherapy. Cancer Lett. 2025;610:217350.","journal-title":"Cancer Lett"},{"key":"1110_CR24","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1007\/s00330-024-11246-w","volume":"35","author":"F Wang","year":"2025","unstructured":"Wang F, Xu X, Xu J, Li F, Zhang H, Wang L, et al. Exploring the value of multiparametric quantitative MRI in the assessment of pancreatic ductal adenocarcinoma fibrosis grading. Eur Radiol. 2025;35:3625\u201337.","journal-title":"Eur Radiol"},{"key":"1110_CR25","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1002\/ijc.35326","volume":"156","author":"Y Liu","year":"2025","unstructured":"Liu Y, Xue R. Pancreatic stellate cell: Update on molecular investigations and clinical translation in pancreatic cancer. Int J Cancer. 2025;156:1672\u201385.","journal-title":"Int J Cancer"},{"key":"1110_CR26","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1148\/radiol.2019182561","volume":"292","author":"A Hamdy","year":"2019","unstructured":"Hamdy A, Ichikawa Y, Toyomasu Y, Nagata M, Nagasawa N, Nomoto Y, et al. Perfusion CT to Assess Response to Neoadjuvant Chemotherapy and Radiation Therapy in Pancreatic Ductal Adenocarcinoma: Initial Experience. Radiology. 2019;292:628\u201335.","journal-title":"Radiology"},{"key":"1110_CR27","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3892\/ol.2025.15325","volume":"30","author":"H Maehira","year":"2025","unstructured":"Maehira H, Maekawa T, Tsuji Y, Mori H, Nitta N, Sonoda T, et al. Dynamic changes in tumor blood flow during chemotherapy: Implications in customized treatment for pancreatic cancer. Oncol Lett. 2025;30:579.","journal-title":"Oncol Lett"},{"key":"1110_CR28","doi-asserted-by":"publisher","first-page":"107958","DOI":"10.1016\/j.phrs.2025.107958","volume":"221","author":"W Cai","year":"2025","unstructured":"Cai W, Chen Y, Dai S, Zhao J, Chen L. Hyaluronic acid and its role in pancreatic cancer: Mechanisms of tumor progression, drug resistance, and therapeutic targeting. Pharmacol Res. 2025;221:107958.","journal-title":"Pharmacol Res"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-026-01110-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-026-01110-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-026-01110-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:10:27Z","timestamp":1788336627000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40644-026-01110-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1110"],"URL":"https:\/\/doi.org\/10.1186\/s40644-026-01110-z","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. This retrospective study was approved by the First Affiliated Hospital of the University of Science and Technology of China (Approval No.2025-KY-464). Due to the retrospective nature of the study, written informed consent from participants was waived. This study was conducted in accordance with the Declaration of Helsinki and its subsequent amendments.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"115"}}